Hi, we are looking for gut microbiome by targeting V3V4 and ITS2 regions through Illumina-MiSeq platform and would like to analyse the data using QIIME and other bioinformatics pipelines. Our data consists of 500,000 to 800,000 reads per sample. The comparative analysis would range from 40 to 100 samples (maximum). In this regard, it would be grateful, if someone tell us the suitable configuration (RAM, hard disk space, processor, number of cores, number of threads etc) for buying the workstation.
-
-
Are you working within a certain budget or is that not a consideration?
You will find several workstation threads here (and elsewhere on the net) and most of those recommendations should work well for you. In general try to maximize the RAM, get a solid state drive for OS, go with the second or third fastest processor(s) you can afford (not much gain in getting the top of the line/most expensive CPU) and finally as much spinning disk as you can fit in your remaining budget. -
Minimum configuration required for analyzing MiSeq data (by V3V4, ITS2) on QIIME
Hi GenoMax, thankyou for your reply. I would like to know the minimum configuration required for analyzing the data which I have posted earlier, so that I can plan for a workstation within our budget accordingly. [Whether 32 GB RAM, Intel® Core™ i7-6700 CPU @ 3.40GHz × 8 processor (http://ark.intel.com/products/88196/...up-to-4_00-GHz) , 1 TB hard disk space are sufficient and optimal for such analysis?, if higher configuration is required, what will you suggest?].Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment